CLVS Stock News

Popular stocks:

NVIDIA

TOP Stocks:

Shares of other companies:

Electra Battery Materials

Astra Space

Snap

Clever Leaves Holdings

Clovis Oncology (CLVS) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 3, 2023 (06:25)

Sector: Healthcare

The share price of Clovis Oncology, Inc. (CLVS) now

What analysts predict: $

52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Clovis Oncology stocks, the 50-day moving average is the support level today.

For Clovis Oncology stocks, the 200-day moving average is the support level today.

Are you interested in Clovis Oncology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Clovis Oncology stock price in 2024, 2025, 2026, 2027, 2028. How much will one Clovis Oncology share be worth in 2024 - 2028?

When should I take profit in Clovis Oncology stock? When should I record a loss on Clovis Oncology stock? What are analysts' forecasts for Clovis Oncology stock? What is the future of Clovis Oncology stock? We forecast Clovis Oncology stock performance using neural networks based on historical data on Clovis Oncology stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Clovis Oncology stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Clovis Oncology shares. This happens once a day.

Historical and forecast chart of Clovis Oncology stock

The chart below shows the historical price of Clovis Oncology stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Clovis Oncology stock price can be found in the table below.

Long-term forecasts by years.

Clovis Oncology, Inc., a biopharmaceutical company, specializes in the acquisition, development and commercialization of anti-cancer agents in the United States, the European Union and internationally. The company offers Rubraca (rucaparib), an oral small molecule poly-ADP-ribose polymerase inhibitor for the treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Clovis Oncology daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Dec 05	0.08	0.08	0.09	8.13
Dec 06	0.09	0.08	0.09	7.94
Dec 07	0.08	0.08	0.08	6.70
Dec 08	0.08	0.08	0.08	7.45
Dec 09	0.08	0.08	0.09	6.95
Dec 10	0.09	0.09	0.09	5.91
Dec 11	0.09	0.09	0.09	3.42
Dec 12	0.09	0.08	0.09	6.40
Dec 13	0.09	0.09	0.09	5.44
Dec 14	0.08	0.08	0.09	3.81
Dec 15	0.09	0.08	0.09	6.27
Dec 16	0.09	0.09	0.09	4.54
Dec 17	0.09	0.09	0.09	4.91
Dec 18	0.09	0.09	0.09	8.70
Dec 19	0.09	0.09	0.10	5.01
Dec 20	0.09	0.09	0.10	4.04
Dec 21	0.10	0.09	0.10	9.13
Dec 22	0.10	0.10	0.10	7.08
Dec 23	0.10	0.09	0.10	6.62
Dec 24	0.09	0.09	0.10	7.75
Dec 25	0.09	0.09	0.10	9.71
Dec 26	0.09	0.08	0.09	8.56
Dec 27	0.09	0.08	0.09	8.51
Dec 28	0.09	0.09	0.10	6.06
Dec 29	0.09	0.09	0.09	6.14
Dec 30	0.09	0.09	0.10	6.88
Dec 31	0.09	0.09	0.09	4.82
Jan 01	0.09	0.09	0.09	6.24
Jan 02	0.08	0.08	0.09	7.41
Jan 03	0.08	0.08	0.09	7.67

Clovis Oncology Daily Price Targets

Clovis Oncology Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $0.08.
Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 7.515%.
Pessimistic target level: 0.08
Optimistic target level: 0.09

Clovis Oncology Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $0.09.
Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 7.359%.
Pessimistic target level: 0.08
Optimistic target level: 0.09

Clovis Oncology Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $0.08.
Negative dynamics for Clovis Oncology shares will prevail with possible volatility of 6.277%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

Clovis Oncology Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $0.08.
Negative dynamics for Clovis Oncology shares will prevail with possible volatility of 6.938%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

Clovis Oncology Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $0.08.
Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 6.502%.
Pessimistic target level: 0.08
Optimistic target level: 0.09

Clovis Oncology Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $0.09.
Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 5.579%.
Pessimistic target level: 0.09
Optimistic target level: 0.09

CLVS (CLVS) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan.	0.10	0.08	0.11	27.82
Feb.	0.11	0.09	0.12	25.85
Mar.	0.10	0.10	0.13	21.98
Apr.	0.11	0.09	0.12	22.57
May.	0.08	0.07	0.09	22.86
Jun.	0.10	0.08	0.11	23.37
Jul.	0.10	0.09	0.11	17.54
Aug.	0.11	0.09	0.13	34.81
Sep.	0.11	0.10	0.13	25.29
Oct.	0.14	0.12	0.16	27.13
Nov.	0.13	0.12	0.14	13.57
Dec.	0.12	0.10	0.15	30.10

Full forecast for 2024

Clovis Oncology forecast for this year

Clovis Oncology Stock Prediction for Jan 2024

An uptrend is forecast for this month with an optimal target price of $0.102572. Pessimistic: $0.08. Optimistic: $0.11

Clovis Oncology Stock Prediction for Feb 2024

An uptrend is forecast for this month with an optimal target price of $0.107741. Pessimistic: $0.09. Optimistic: $0.12

Clovis Oncology Stock Prediction for Mar 2024

An downtrend is forecast for this month with an optimal target price of $0.104725. Pessimistic: $0.10. Optimistic: $0.13

Clovis Oncology Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $0.105604. Pessimistic: $0.09. Optimistic: $0.12

Clovis Oncology Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $0.0801748. Pessimistic: $0.07. Optimistic: $0.09

Clovis Oncology Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $0.10195. Pessimistic: $0.08. Optimistic: $0.11

Clovis Oncology Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $0.102236. Pessimistic: $0.09. Optimistic: $0.11

Clovis Oncology Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $0.113114. Pessimistic: $0.09. Optimistic: $0.13

Clovis Oncology Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $0.111847. Pessimistic: $0.10. Optimistic: $0.13

Clovis Oncology Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $0.142851. Pessimistic: $0.12. Optimistic: $0.16

Clovis Oncology Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $0.130851. Pessimistic: $0.12. Optimistic: $0.14

Clovis Oncology Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $0.123157. Pessimistic: $0.10. Optimistic: $0.15

Clovis Oncology (CLVS) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.13	0.12	0.14	15.36
Feb	0.15	0.12	0.17	31.77
Mar	0.19	0.15	0.23	32.62
Apr	0.21	0.17	0.25	33.32
May	0.20	0.17	0.23	24.75
Jun	0.20	0.17	0.23	27.78
Jul	0.18	0.17	0.22	25.28
Aug	0.15	0.13	0.18	29.39
Sep	0.13	0.11	0.15	26.62
Oct	0.12	0.10	0.13	27.92
Nov	0.09	0.07	0.10	30.76
Dec	0.10	0.09	0.13	27.74

Full forecast for 2025

Clovis Oncology (CLVS) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.12	0.09	0.13	25.64
Feb	0.13	0.11	0.16	31.51
Mar	0.16	0.13	0.19	30.40
Apr	0.16	0.13	0.19	32.22
May	0.12	0.10	0.13	23.01
Jun	0.13	0.12	0.14	13.40
Jul	0.14	0.13	0.17	23.25
Aug	0.18	0.16	0.22	26.21
Sep	0.19	0.17	0.21	18.73
Oct	0.18	0.16	0.22	24.42
Nov	0.17	0.15	0.19	21.71
Dec	0.19	0.16	0.23	28.63

Full forecast for 2026

Clovis Oncology (CLVS) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	0.18	0.15	0.22	30.79
Feb	0.22	0.20	0.25	21.42
Mar	0.20	0.17	0.24	29.66
Apr	0.21	0.17	0.24	28.99
May	0.17	0.13	0.19	30.53
Jun	0.18	0.16	0.20	18.31
Jul	0.19	0.15	0.20	24.53
Aug	0.21	0.18	0.24	24.87
Sep	0.19	0.16	0.22	26.91
Oct	0.20	0.16	0.22	26.10
Nov	0.17	0.14	0.20	30.42
Dec	0.16	0.14	0.19	25.57

Full forecast for 2027

Clovis Oncology (CLVS) Monthly Stock Prediction for 2028

Month	Target	Pes.	Opt.	Vol., %
Jan	0.15	0.13	0.17	24.81
Feb	0.17	0.15	0.18	18.27
Mar	0.17	0.14	0.18	19.52
Apr	0.17	0.15	0.19	23.48
May	0.17	0.16	0.19	15.74
Jun	0.13	0.11	0.14	18.73
Jul	0.13	0.11	0.14	23.83
Aug	0.12	0.11	0.15	28.37
Sep	0.11	0.09	0.12	27.52
Oct	0.12	0.11	0.14	22.52
Nov	0.13	0.12	0.16	22.13
Dec	0.13	0.12	0.15	19.40

Full forecast for 2028

Clovis Oncology information and performance

Clovis Oncology Address

N/A

Market Capitalization: N/A $

Market capitalization of the Clovis Oncology, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CLVS shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Clovis Oncology is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

G1 Therapeutics, Inc. (GTHX)

Catalent, Inc. (CTLT)

Second Sight Medical Products, Inc. (EYES)

Galera Therapeutics, Inc. (GRTX)

Agilent Technologies, Inc. (A)

GoodRx Holdings, Inc. (GDRX)

Spruce Biosciences, Inc. (SPRB)

Incyte Corp. (INCY)

NLS Pharmaceutics AG (NLSP)

Editas Medicine, Inc. (EDIT)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/CLVS.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/CLVS.svg"> Clovis Oncology (CLVS) Stock Forecast for 2023 – 2026. Sell or Buy?